Instructions for the Authors of Szemészet (szemeszet.ophthalmol.hungarica.eu)
Aims of the Journal:
- Publishing high quality original articles, both clinical and scientific, on all aspects of ophthalmological medicine
- Assisting the professional education of ophthalmologists with the publication of relevant and interesting systematic reviews
- Publishing professional guidelines and working group statements.
- Expanding the knowledge of internal physicians and general practitioners in the field of Ophthalmology
- Original clinical or experimental articles
- Case reports
- Systematic reviews
- Consensus and position papers
1. Peer Review process
The corresponding author submits the paper to the Szemészet ( szemeszet.ophthalmol.hungarica.eu ) via an online system (www.editor.olo.hu). Occasionally journals may accept submissions by email.
The journal checks the paper’s composition and arrangement based on the journal’s instructions for authors to make sure it includes the required sections.
The editor-in-chief checks if the submitted article is appropriate for the journal and is sufficiently original and actually interesting. If it is not, the paper may be rejected without being reviewed any further (within 7 days).
The editorial office sends invitations to individuals considered to be appropriate reviewers. As responses are received, further invitations are issued. Generally, 2 reviewers are invited.
Potential reviewers consider the invitation based on their own expertise, conflicts of interest and availability. They then accept or decline it. When declining, they might also suggest alternative reviewers (in similar research or interest area).
Generally, the reviewers have 21 days to prepare their reviews.
Reviews will be uploaded to www.editor.olo.hu and can be viewed only by the author (and editor-in-chief) using their access code. After the review is finalized, the author will be notified by e-mail.
The reviewer takes their time to read and to elucidate the paper several times. If the reviewer finds major problems during the first read, they may feel comfortable rejecting the paper without further analysis. The review is then submitted to the journal, with a recommendation to accept or reject it – or else with a request for revision (usually flagged as either major or minor) before it is reconsidered.
The editor-in-chief considers all the received reviews before making an overall decision. If the reviews differ widely, the editor may invite an additional reviewer in order to get a supplementary opinion before making a final decision.
The editorial secretary sends an e-mail with the decision to the author including any relevant reviewer comments. The comments are always anonymous.
If accepted, the paper is sent to production. If the article is rejected or sent back for either major or minor revision, the reviewers should also be sent an email or letter letting them know about the outcome of their review. If the paper is sent back for revision, the reviewers should expect to receive a new version.
2. Manuscript Preparation
2.1. Basic information (title, authors, contact)
The concise title of the manuscript in Hungarian and English (up to 100 characters with spaces, no abbreviations). Full name and title of the authors (in the case of a doctoral degree it must be indicated after the name). Affiliations of the authors (name of the institute and department, city, head of department). The address and e-mail address of the correspondent author.
The abstract should summarize briefly the most important findings of the manuscript – the purpose of the research, methods, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. It should contain the numerical results of the work. It should not contain abbreviations. All abstracts must be restricted in length to 300 words. It must be copied separately into the windows reserved for them.
Both in Hungarian and in English. The maximum number of keywords is 5.
2.3 Body text
Introduction: It contains a brief retrospective summary; long historical descriptions must be avoided. Specific questions, the purpose and the significance of the study must be formulated. The introduction should only mention the most important literary references.
The types and formal requirements of the manuscripts
Original article: (Abstract: Purpose, Methods, Results, Conclusion),
(Body text: Introduction, Aims, Methods, Results, Discussion, Conclusion) with keywords (max.5) and references
Case Report: (Abstract: without any required structure),
(Body text: Introduction, Case report, Discussion) with keywords (max.5) and references
Review: abstract and body text without any required structure with keywords (max.5) and references
Patients and Methods: The methods used, and the patient groups should be accurately described, and the formulation should be concise. The type of equipment used, and the name and manufacturer of the materials used should be specified accurately. Drugs should be referenced by their generic name. Statistical methods must be described in such detail that a competent reader should be able to judge the planning and execution of the test, as well as assess the results. If the planning and the statistical methods of the study are based on standard work, it is enough to make a reference in the literature, instead of a detailed description. For animal tests, precise identification of the animals should be provided, and the dose should be given for medicinal products. In clinical trials, statistics on the patient population (gender, age) and the method of selection should be described. When research results involving humans are published, it is sufficient just to indicate the license number of the ethical permission, and the identity of the person who issued the permit in the manuscript, but the written approval of the Ethics Committee must be attached – Patients and Methods: The methods used, and the patient groups should be accurately described, and the formulation should be concise. The type of equipment used, and the name and manufacturer of the materials used should be specified accurately. Drugs should be referenced by their generic name. Statistical methods must be described in such detail that a competent reader should be able to judge the planning and execution of the test, as well as assess the results. If the planning and the statistical methods of the study are based on standard work, it is enough to make a reference in the literature, instead of a detailed description. For animal tests, precise identification of the animals should be provided, and the dose should be given for medicinal products. In clinical trials, statistics on the patient population (gender, age) and the method of selection should be described. When research results involving humans are published, it is sufficient just to indicate the license number of the ethical permission, and the identity of the person who issued the permit in the manuscript, but the written approval of the Ethics Committee must be attached.
Results: The main results of the study should be described. The results should be clear and concise. In the case of statistical processing, the level of significance and the confidence intervals are also required.
Discussion, Conclusions: A possible explanation of the results and a comparison with the literature data should be provided. It is necessary to describe the relations between the objective and the results. It is also essential to clarify the clinical relevance of the results. Hypotheses yet to be scientifically justified should be avoided but at the same time it is necessary to indicate the emerging questions, which require further processing. Especially in cases where the goal is to decide clinical applicability.
2.4. Supporters, Acknowledgments: Optional
Only those publications that are referred to in the text may be included in the References. Only published data can be referenced. The only exceptions are articles accepted for publication, which must be clearly stated. References in the text, in the tables, in the explanations of figures should be numbered in the order of reference. Numbering should be indicated in parentheses with Arabic numerals, written before the punctuation at the end of the sentence, e.g.: (1). The References should also be sorted this way, not in alphabetical order. The form of the citations should be based on the following examples, which are based on the Vancouver Agreement („Uniform requirements for manuscripts submitted to biomedical journals”). Please indicate the available DOI numbers of the literature cited in the References.
Article citation example:
Author(s), title of article, name of journal, year, volume, page number.
Example: Jaulim A, Ahmed B, Khanam T, Chatziralli IP. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina. 2013 May;33(5):901-10. doi: 10.1097/IAE.0b013e3182870c15.
Book citation example:
Author(s), book title, issue number, place, publisher, year.
Example: Mandl, H., De Corte, E., Bennett, N. és Friedrich, H. F.: Learning and instruction. European research in an international context. Volume 2.1. Social and cognitive aspects of learning and instruction. Pergamon Press, Oxford, 1990.
Chapter citation example:
Author (s), Title of Book Chapter, Name(s) of Editor(s), Title of Book, Issue Number, Place, Publisher, Year, Page Number.
Example: Neves, D. M. és Anderson, J. R.: Knowledge compilation: Mechanisms for the automatization of cognitive skills. In: Anderson, J. R. (edit.): Cognitive skills and their acquisition. Lawrence Erlbaum Associates, Publishers, Hillsdale, (1981) 57-84.
Webpage citacion example: http://szemeszet.ophthalmol.hungarica.eu
2.6. Tables, Figures and Pictures, Graphic texts
Do not insert tables or figures in the text, just refer to them. Each table, figure, and image should have an explanation text which is self-evident.
3. Notes on Spelling
Spelling in English: Oxford English spelling should be used. Authors with English as a second language are requested to have their manuscripts proofread before submission. This will greatly help expedite the review process by helping to ensure that the academic content of the paper is fully understood by journal editors and reviewers.
- Latin should be used in the Latin word order for the names of anatomical, pathological, physiological and histological names, pathogens, diseases and surgical procedures, as well as patented medicinal names.
- Abbreviations must be written in parentheses in the first place displayed, after the word to be abbreviated.
- The results of laboratory tests should preferably be given in standard SI units, temperature in °C, blood pressure in mmHg. If necessary, the old imperial unit may also be indicated in parentheses after the SI unit.
To achieve a consistent spelling, Szemészet (szemeszet.ophthalmol.hungarica.eu) reserves the right to modify the spelling of words other than those specified.
4. Formal requirements
One single type of font is to be used in the text.
There are no restrictions in the case of symbols and special characters.
Format of Tables: in MS Word.
Format of Graphics: JPG.
Format of images: JPG in 300 dpi resolution.
5. Statements and permissions
In the cover letter the authors should declare about the following:
- Transfer of copyright
- Compliance with international ethical standards
- Declaration on republication
- Financial relationship
- Patient’s consent statement if necessary
- Permission of Ethics Committee if necessary
- Permission from the publishing house, in the case of republication and figures, if necessary.
Copyright information, compliance with ethical standards, financial relations:
Publishing rights are entitled to the author(s) until publication, which is automatically transferred to the Editorial Board and the Publisher unless specified otherwise by the author at the time of submission. When submitting the manuscript, the author should declare in a signed cover letter that the dissertation is the first publication, which is offered to Promenade Publishing House for publication in Szemészet, and it is known and accepted by all authors and there is no conflict of interest. Thereafter the Editorial Board and the Publisher are entitled to have global copyright. The Publisher does not reject the request for republication. Further republication is not generally accepted.
A different practice can be applied, when:
The material was published in the form of an abstract or a poster in a preliminary report regarding a scientific meeting, or a part of it has been published in the form of a proceedings regarding a scientific event.
The republication will be published in a different language (e.g.: in the mother tongue), in which case a written permission from the publisher should be provided. In the cover letter, all authors must declare that they have complied with the international ethical standards. Patients have the fundamental right to preserve their anonymity, which can only be ignored if the patient received detailed information and their written agreement is attached by the author. Information which can be used to identify the person (text, graphics) can only be published with the consent of the patient. In the case of clinical trials which require permission from the Ethics Committee, please attach a copy of the permit. All authors must declare whether they have a financial conflict of interests with the manufacturer / distributor of the diagnostic or therapeutic procedure / active substance, or with the sponsors of the procedures described in the study. The Editorial Board reserves the right to present this fact in the study in the case of a major financial relationship.
6. Statement of Human and Animal Rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors are requested to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
7. Data sharing policy
The report of clinical trials must contain a data sharing statement. Clinical trials that began enrolling participants on or after 1 January 2019 must include a data sharing plan in the submission. If the data sharing plan changes, this should be reflected in the statement submitted and published with the manuscript.
The following information must be contained in the date sharing statements: whether individual deidentified participant data will be shared; what data will be shared; whether additional documents will be available (study protocol, statistical analysis plan, etc.); when and for how long the data will become available; with whom will the data be shared for what types of analyses and by what mechanism will the data be available. Authors of secondary analyses of the shared data must acknowledge that their use was in accordance with the terms agreed to upon their receipt.
8. Submitting the Manuscript
The completed manuscript can only be submitted electronically after registration on www.editor.olo.hu. We hope you find this electronic manuscript management system user-friendly. Please find some useful information below to make it easier to use:
New authors: Click on the Register button and enter the required information. After a successful registration, you will receive an email notification on how to activate your registration.
Other authors: Use your existing login details to enter as an author and then manually upload your manuscript step by step.
Once you have uploaded your manuscript, the system automatically performs a PDF conversion. After reviewing the PDF version, you need to confirm your intention to submit the manuscript.
Reviewers: After registration or using an existing access code, enter as a reviewer. Then the manuscript waiting for review can be accessed and the opinion of the reviewer can be uploaded.
Forgotten login details: Click on the login button and then on the forgotten access code and follow the instructions.
Advertisements can be published only after the approval of Publisher, which also reserves the right to reject or cancel the publication at any time.
Publisher warrants, that the entire contents of the accepted advertisements will be published, except for libelling, violation of privacy, copyright infringement or plagiarism. In these cases the publication of advertisements can be cancelled at any time.
The advertiser must be clearly identified in every advertisements.
In case of pharmaceutical ads, the names of the products must be accompanied by the generic, chemical or official name along with the quantity of all active substances with the recommended dosage.
Publisher is not responsible for any incidental damage or errors occurring during processing or printing the ad.
Advertiser warrants that all products they advertise are compliant with all applicable laws and regulations in Hungary (Act XLVIII of 2008 on the Basic Requirements and Certain Restrictions of Commercial Advertising Activities, Act XCVIII of 2006 on the General Provisions Relating to the Reliable and Economically Feasible Supply of Medicinal Products and Medical Aids and on the Distribution of Medicinal Products, https://jogtar.hu/)